ARCHIVES

In Brief: No Decision Yet On How CALB Cuts Will Be Made; Wyngaarden Of Duke Will Be New Director of NIH

This article is from The Cancer Letter archive.

Vol. 08 No. 05 | January 29, 1982

Download PDF Visit The Full Archive

Related Articles

DRCCA Board Changes Center Core Grants Guidelines To Permit Payment for Control Program Directors

October 29, 1982

Dendritic Cell Vaccine May Boost Median Survival

March 25, 2011

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

Scientists Tell Panel: Peer Review Need Improving, Available Funds Should Be Spread Over More Grants

April 30, 1982

In Brief: New Biomedical Research Panel To Organize Feb. 24-25, Discuss Mandate, Priorities

February 14, 1975

Kessler Promises Cancer Patient Liaison In FDA; Considers Joint Drugs, Biologics Oncology Review

August 14, 1992